FR2850579B1 - Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no - Google Patents

Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no

Info

Publication number
FR2850579B1
FR2850579B1 FR0301210A FR0301210A FR2850579B1 FR 2850579 B1 FR2850579 B1 FR 2850579B1 FR 0301210 A FR0301210 A FR 0301210A FR 0301210 A FR0301210 A FR 0301210A FR 2850579 B1 FR2850579 B1 FR 2850579B1
Authority
FR
France
Prior art keywords
donor
vitamin
mono
esters
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0301210A
Other languages
English (en)
Other versions
FR2850579A1 (fr
Inventor
Grierson Marie Madeleine Cals
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0301210A priority Critical patent/FR2850579B1/fr
Priority to CA002456031A priority patent/CA2456031A1/fr
Priority to EP04290253A priority patent/EP1442739A1/fr
Priority to JP2004027167A priority patent/JP2004307470A/ja
Priority to US10/769,796 priority patent/US20040220260A1/en
Publication of FR2850579A1 publication Critical patent/FR2850579A1/fr
Application granted granted Critical
Publication of FR2850579B1 publication Critical patent/FR2850579B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
FR0301210A 2003-02-03 2003-02-03 Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no Expired - Fee Related FR2850579B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0301210A FR2850579B1 (fr) 2003-02-03 2003-02-03 Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
CA002456031A CA2456031A1 (fr) 2003-02-03 2004-01-29 Utilisation de mono- ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
EP04290253A EP1442739A1 (fr) 2003-02-03 2004-01-30 Utilisation de mono- ou di-esters d'acide cinnamique ou de l'un de ses dérivés et de vitamine C, comme donneur de NO.
JP2004027167A JP2004307470A (ja) 2003-02-03 2004-02-03 Ｎｏ供与体としてのケイ皮酸またはその誘導体とビタミンｃとのモノエステルまたはジエステルの使用
US10/769,796 US20040220260A1 (en) 2003-02-03 2004-02-03 Use of mono-or di-esters of cinnamic acid or of one of its derivatives and vitamin C, as donor of NO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0301210A FR2850579B1 (fr) 2003-02-03 2003-02-03 Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no

Publications (2)

Publication Number Publication Date
FR2850579A1 FR2850579A1 (fr) 2004-08-06
FR2850579B1 true FR2850579B1 (fr) 2006-08-18

Family

ID=32696307

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0301210A Expired - Fee Related FR2850579B1 (fr) 2003-02-03 2003-02-03 Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no

Country Status (3)

Country Link
US (1) US20040220260A1 (fr)
JP (1) JP2004307470A (fr)
FR (1) FR2850579B1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5042209B2 (ja) 2005-03-24 2012-10-03 ノーラブズ エービー 酸化窒素による美容治療、前記治療を実施する装置、及びその製造方法
US8591876B2 (en) * 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2013006608A1 (fr) 2011-07-05 2013-01-10 Novan, Inc. Compositions topiques
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
JP6513667B2 (ja) 2013-08-08 2019-05-15 ノヴァン，インコーポレイテッド 局所用組成物およびそれを使用する方法
WO2016022170A1 (fr) 2014-08-08 2016-02-11 Novan, Inc. Émulsions topiques
KR102319497B1 (ko) 2016-03-02 2021-11-01 노반, 인크. 염증 치료용 조성물 및 염증 치료 방법
KR102426006B1 (ko) 2016-04-13 2022-07-29 노반, 인크. 감염 치료용 조성물, 시스템, 키트, 및 방법
CN115350110B (zh) * 2022-07-26 2024-08-02 长春圣博玛生物材料有限公司 维生素c乳酸酯及其类似物在制备皮肤组织用制品中的用途及其相关制品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2529511A1 (de) * 1975-07-02 1977-01-20 Henkel & Cie Gmbh Sonnenschutzmittel fuer die menschliche haut
FR2673179B1 (fr) * 1991-02-21 1993-06-11 Oreal Ceramides, leur procede de preparation et leurs applications en cosmetique et en dermopharmacie.
FR2715156B1 (fr) * 1994-01-20 1996-03-01 Oreal Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires.
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
FR2788689B1 (fr) * 1999-01-27 2002-06-07 Oreal Composition cosmetique comprenant au moins une cire et au moins un compose de type ceramide et procedes
FR2795638B1 (fr) * 1999-07-02 2003-05-09 Oreal Compositions cosmetiques photoprotectrices et utilisations
FR2807320B1 (fr) * 2000-04-10 2002-05-24 Oreal Utilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux

Also Published As

Publication number Publication date
JP2004307470A (ja) 2004-11-04
FR2850579A1 (fr) 2004-08-06
US20040220260A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
WO2004001019A3 (fr) Nouvelles nanoparticules et leur utilisation
FR2816838B1 (fr) Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
NO20010013L (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
DE19775083I2 (de) 7-Piperazinyl-oder 7-Morpholino-4-oxo-chinolin-3-carbonsaeurederivate ihre Herstellung und ihre Verwendung als antimikrobielle Mittel
FR2852229B1 (fr) Prothese totale d'epaule.
TR200200716T2 (tr) Ketiyapin granülleri
FR2850579B1 (fr) Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
DE60035059D1 (de) Mittel zur verbesserung der hauttextur
AR024380A1 (es) Tienopirimidinas
FR2809000B1 (fr) Utilisation d'ergothioneine et/ou de ses derives comme agent anti-pollution
CA2305933A1 (fr) Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
PT1173756E (pt) Medicao das concentracoes de fluidos
WO2003001182A3 (fr) Transthyretine homocysteinylee
BR0108405A (pt) Agente de ativação de célula
FR2850578B1 (fr) Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
ATE241640T1 (de) Fusidinsäure-derivate
WO2002070537A3 (fr) Derives d'acide fusidique
WO2001052654A3 (fr) Combinaison d'agents biologiques et chimiques de lutte contre les rongeurs
DE50203525D1 (de) Tetrahydroisochinoline, ihre herstellung und verwendung als schmerzmittel
ATE368383T1 (de) Gewürzkrautzubereitung

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081031